Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

FDA approves phase Ib ibudilast trial in methamphetamine-dependent subjects

Sep. 29, 2010

FDA committee recommends approval of Vivitrol for opioid dependence

Sep. 20, 2010

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

Cellerant awarded BARDA contract to develop ARS treatment

Sep. 2, 2010

ImmuneRegen to submit proposal for funding Homspera development

Sep. 1, 2010

FDA approves Suboxone sublingual film

Sep. 1, 2010

BTG to receive marketing rights for Nycomed's CroFab and DigiFab

Sep. 1, 2010

Escitalopram prevents relapse in patients with alcoholism and comorbid affective disorders

Aug. 31, 2010

Risperidone may have the potential to treat alcohol dependence

Aug. 30, 2010

NIH renews research funding for Homspera in radiation-induced lung injury

Aug. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...